Tools for characterizing bacterial protein synthesis inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 12, 2013, Pages 5994-6004

  Orelle, Cédric ^a   Carlson, Skylar ^a   Kaushal, Bindiya ^a   Almutairi, Mashal M ^a   Liu, Haipeng ^a   Ochabowicz, Anna ^a   Quan, Selwyn ^b   Pham, Van Cuong ^c   Squires, Catherine L ^b   Murphy, Brian T ^a   Mankin, Alexander S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b STANFORD UNIVERSITY   (United States)

^c GRADUATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BACTERIAL RNA; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN; EFEPRISTIN; ERYTHROMYCIN; EVERNIMICIN; FLORFENICOL; GENTAMICIN; KANAMYCIN; KASUGAMYCIN; LINEZOLID; MESSENGER RNA; PACTAMYCIN; PROTEIN SYNTHESIS INHIBITOR; RIBOSOME RNA; TELITHROMYCIN; TETRACYCLINE; THIOSTREPTON; TIAMULIN; TYLOSIN; VOLPRISTIN; ANTIINFECTIVE AGENT; PRIMER DNA;

ALLELE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; OPERON; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RIBOSOME; CELL FRACTIONATION; CHEMISTRY; CONFORMATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC ENGINEERING; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID CONFORMATION; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; RIBOSOMES; RRNA OPERON; SUBCELLULAR FRACTIONS;

EID: 84887462372     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01673-13     Document Type: Article

References (57)

1. Levy SB, Marshall B. 2004. Antibacterial resistance worldwide: causes, challenges, and responses. Nat. Med. 10:S122-S129.
2. Newman DJ, Cragg GM. 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75:311-335.
3. Li J, Vederas J. 2009. Drug discovery and natural products: end of an era or an endless frontier? Science 325:161-165.
4. Peach KC, Bray WM, Winslow D, Linington PF, Linington RG. 2013. Mechanism of action-based classification of antibiotics using highcontent bacterial image analysis. Mol. Biosyst. 9:1837-1848.
5. Schulze CJ, Bray WM, Woerhmann MH, Stuart J, Lokey RS, Linington RG. 2013. "Function-first" lead discovery: mode of action profiling of natural product libraries using image-based screening. Chem. Biol. 20: 285-295.
6. Wong WR, Oliver AG, Linington RG. 2012. Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics. Chem. Biol. 19:1483-1495.
7. Wilson DN. 2009. The A-Z of bacterial translation inhibitors. Crit. Rev. Biochem. Mol. Biol. 44:393-433.
8. Poehlsgaard J, Douthwaite S. 2005. The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol. 3:870-881.
9. Hummel H, Bock A. 1987. Thiostrepton resistance mutations in the gene for 23S rRNA of halobacteria. Biochimie 69:857-861.
10. Hummel H, Bock A. 1987. 23S rRNA mutations in halobacteria conferring resistance to the anti-80S ribosome targeted antibiotic anisomycin. Nucleic Acids Res. 15:2431-2443.
11. Gregory ST, Dahlberg AE. 2009. Genetic and structural analysis of base substitutions in the central pseudoknot of Thermus thermophilus 16S rRNA. RNA 15:215-223.
12. Monshupanee T, Gregory ST, Douthwaite S, Chungjatupornchai W, Dahlberg AE. 2008. Mutations in conserved helix 69 of 23S rRNA of Thermus thermophilus that affect capreomycin resistance but not posttranscriptional modifications. J. Bacteriol. 190:7754-7761.
13. Sander P, Prammananan T, Bottger EC. 1996. Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon. Mol. Microbiol. 22:841-848.
14. Sander P, Belova L, Kidan YG, Pfister P, Mankin AS, Bottger EC. 2002. Ribosomal and non-ribosomal resistance to oxazolidinones: speciesspecific idiosyncrasy of ribosomal alterations. Mol. Microbiol. 46:1295-1304.
15. Springer B, Kidan YG, Prammananan T, Ellrott K, Bottger EC, Sander P. 2001. Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. Antimicrob. Agents Chemother. 45:2877-2884.
16. Lambert PA. 2002. Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria. J. Appl. Microbiol. 92(Suppl):46S-54S.
17. Cochella L, Green R. 2004. Isolation of antibiotic resistance mutations in the rRNA by using an in vitro selection system. Proc. Natl. Acad. Sci. U. S. A. 101:3786-3791.
18. Ettayebi M, Prasad SM, Morgan EA. 1985. Chloramphenicolerythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J. Bacteriol. 162:551-557.
19. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
20. Bollenbach T, Quan S, Chait R, Kishony R. 2009. Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139: 707-718.
21. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2:2006-2008.
22. Braun M, Silhavy TJ. 2002. Imp/OstA is required for cell envelope biogenesis in Escherichia coli. Mol. Microbiol. 45:1289-1302.
23. Sampson BA, Misra R, Benson SA. 1989. Identification and characterization of a new gene of Escherichia coli K-12 involved in outer membrane permeability. Genetics 122:491-501.
24. Orelle C, Szal T, Klepacki D, Shaw KJ, Vazquez-Laslop N, Mankin AS. 2013. Identifying the targets of aminoacyl-tRNA synthetase inhibitors by primer extension inhibition. Nucleic Acids Res. 41:e144.
25. Vazquez-Laslop N, Thum C, Mankin AS. 2008. Molecular mechanism of drug-dependent ribosome stalling. Mol. Cell 30:190-202.
26. Vazquez-Laslop N, Ramu H, Klepacki D, Kannan K, Mankin AS. 2010. The key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide. EMBO J. 29:3108-3117.
27. Nikaido H. 2009. Multidrug resistance in bacteria. Annu. Rev. Biochem. 78:119-146.
28. Nikaido H, Pages JM. 2012. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol. Rev. 36:340-363.
29. Asai T, Condon C, Voulgaris J, Zaporojets D, Shen B, Al-Omar M, Squires C, Squires CL. 1999. Construction and initial characterization of Escherichia coli strains with few or no intact chromosomal rRNA operons. J. Bacteriol. 181:3803-3809.
30. Asai T, Zaporojets D, Squires C, Squires CL. 1999. An Escherichia coli strain with all chromosomal rRNA operons inactivated: complete exchange of rRNA genes between bacteria. Proc. Natl. Acad. Sci. U. S. A. 96:1971-1976.
31. Sulavik MC, Houseweart C, Cramer C, Jiwani N, Murgolo N, Greene J, DiDomenico B, Shaw KJ, Miller GH, Hare R, Shimer G. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob. Agents Chemother. 45:1126-1136.
32. Wu T, McCandlish AC, Gronenberg LS, Chng SS, Silhavy TJ, Kahne D. 2006. Identification of a protein complex that assembles lipopolysaccharide in the outer membrane of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 103:11754-11759.
33. Douthwaite S. 1992. Functional interactions within 23S rRNA involving the peptidyltransferase center. J. Bacteriol. 174:1333-1338.
34. Poehlsgaard J, Pfister P, Bottger EC, Douthwaite S. 2005. Molecular mechanisms by which rRNA mutations confer resistance to clindamycin. Antimicrob. Agents Chemother. 49:1553-1555.
35. Recht MI, Douthwaite S, Puglisi JD. 1999. Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J. 18:3133-3138.
36. Mankin AS. 1997. Pactamycin resistance mutations in functional sites of 16 S rRNA. J. Mol. Biol. 274:8-15.
37. Vila-Sanjurjo A, Squires CL, Dahlberg AE. 1999. Isolation of kasugamycin- resistant mutants in the 16 S rRNA of Escherichia coli. J. Mol. Biol. 293:1-8.
38. De Stasio EA, Moazed D, Noller HF, Dahlberg AE. 1989. Mutations in 16S rRNA disrupt antibiotic-RNA interactions. EMBO J. 8:1213-1216.
39. Vester B, Garrett RA. 1987. A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin. Biochimie 69: 891-900.
40. Prunier AL, Malbruny B, Tande D, Picard B, Leclercq R. 2002. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrob. Agents Chemother. 46:3054-3056.
41. Triman KL. 2007. Mutational analysis of the ribosome. Adv. Genet. 58: 89-119.
42. Tenson T, Lovmar M, Ehrenberg M. 2003. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J. Mol. Biol. 330:1005-1014.
43. Hartz D, McPheeters DS, Traut R, Gold L. 1988. Extension inhibition analysis of translation initiation complexes. Methods Enzymol. 164:419-425.
44. Shimizu Y, Inoue A, Tomari Y, Suzuki T, Yokogawa T, Nishikawa K, Ueda T. 2001. Cell-free translation reconstituted with purified components. Nat. Biotechnol. 19:751-755.
45. Kannan K, Vazquez-Laslop N, Mankin AS. 2012. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel. Cell 151:508-520.
46. Belova L, Tenson T, Xiong L, McNicholas PM, Mankin AS. 2001. A novel site of antibiotic action in the ribosome: interaction of evernimicin with the large ribosomal subunit. Proc. Natl. Acad. Sci. U. S. A. 98:3726-3731.
47. Jerinic O, Joseph S. 2000. Conformational changes in the ribosome induced by translational miscoding agents. J. Mol. Biol. 304:707-713.
48. Dujon B. 1980. Sequence of the intron and flanking exons of the mitochondrial 21S rRNA gene of yeast strains having different alleles at the omega and rib-1 loci. Cell 20:185-197.
49. Gregory ST, Carr JF, Rodriguez-Correa D, Dahlberg AE. 2005. Mutational analysis of 16S and 23S rRNA genes of Thermus thermophilus. J. Bacteriol. 187:4804-4812.
50. Li BB, Shen JZ, Cao XY, Wang Y, Dai L, Huang SY, Wu CM. 2010. Mutations in 23S rRNA gene associated with decreased susceptibility to tiamulin and valnemulin in Mycoplasma gallisepticum. FEMS Microbiol. Lett. 308:144-149.
51. Li BB, Wu CM, Wang Y, Shen JZ. 2011. Single and dual mutations at positions 2058, 2503, and 2504 of 23S rRNA and their relationship to resistance to antibiotics that target the large ribosomal subunit. J. Antimicrob. Chemother. 66:1983-1986.
52. Long KS, Munck C, Andersen TM, Schaub MA, Hobbie SN, Bottger EC, Vester B. 2010. Mutations in 23S rRNA at the peptidyl transferase center and their relationship to linezolid binding and cross-resistance. Antimicrob. Agents Chemother. 54:4705-4713.
53. Vester B, Garrett RA. 1988. The importance of highly conserved nucleotides in the binding region of chloramphenicol at the peptidyl transfer centre of Escherichia coli 23S rRNA. EMBO J. 7:3577-3587.
54. Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B. 2006. The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob. Agents Chemother. 50:2500-2505.
55. Smith LK, Mankin AS. 2008. Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors. Antimicrob. Agents Chemother. 52:1703-1712.
56. Jarasch A, Dziuk P, Becker T, Armache JP, Hauser A, Wilson DN, Beckmann R. 2012. The DARC site: a database of aligned ribosomal complexes. Nucleic Acids Res. 40:D495-D500.
57. Gould PS, Bird H, Easton AJ. 2005. Translation toe-printing assays using fluorescently labeled primers and capillary electrophoresis. Biotechniques 38:397-400.